Eczema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women between the ages of 15 and 50 who have been diagnosed with mild to moderate atopic dermatitis (a type of eczema).
- People who are able to understand the study and are willing to formally agree to take part; for those under the legal age of adulthood, a parent or legal guardian must give consent on their behalf.
- Women who are currently pregnant and can be enrolled while the pregnancy is ongoing, or women whose pregnancy has already ended within the last 12 months.
- Women whose pregnancy either involved the use of ruxolitinib cream (at least once during pregnancy) or did not involve any use of ruxolitinib cream — both groups are being studied.
- People for whom contact details are available so that the trial team can follow up over time.
- People who give permission for the trial team to contact their own doctor and their baby's doctor.
Who may not be able to join:
- Women whose pregnancy has already ended more than 12 months before they would be enrolled in the registry.
- People who are currently taking, or have taken within the last 30 days (or longer, depending on the medication), another experimental or investigational medication, or who are already enrolled in another investigational drug study.
- Pregnancies where the woman was exposed to any other medication in the same drug class as ruxolitinib (called JAK inhibitors) during a specific window from the start of pregnancy through at least the end of the first trimester, or through the full pregnancy for certain outcomes (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1.833.917.8791
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of major congenital malformation (MCM)s
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.